You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股配售 | 京東健康一手中籤率40%,申購人數逾84萬,公開認購421.91倍,國配31.1倍
uSMART盈立智投 12-07 11:37

uSMART盈立智投12月7日消息,京東健康發佈《發售價及配發結果公告》。

配售小結】

①分配偏向一手黨:一手黨高達35.39萬人,一手中籤率高達40%,逾14萬名一手黨中籤,而穩中1手則需要申購200手。

②乙組火爆:申購人數高達84.62萬,爲今年以來的申購人數之最(除螞蟻集團外),其中乙組人數高達3萬+,乙組認購倍數(658.94倍)更是甲組的3.5倍,乙組競爭激烈,中籤率也進一步被稀釋,乙頭(申購1600手)中籤7手,中籤市值2.47萬港元,打和點約12%,乙組第二檔(申購1800手)僅穩7爭8。

③京東健康VS阿里健康:京東健康的上市市值爲2208億港元(超額配股權未獲行使前),阿里健康最新市值爲3033.89億港元,對標阿里健康,京東健康約有37%的上升空間,此外,據此前媒體報道,國際場外暗盤交易錄得27%的漲幅。

【配售簡況】

1、發售價:70.58港元,爲招股價區間(62.8-70.58港元)的上限

2、一手市值:3529港元,每手50股

3、有效申購人數:846,209名(甲組:815,421名,乙組:30,788名)

4、實際中籤人數:417,165名

5、中籤情況:一手中籤率40%,申購200手穩中1手,甲尾中4手,乙頭中7手,頂頭槌中401手

6、公開認購倍數:約421.91倍(甲組:184.88倍,乙組:658.94倍)

7、國際配售:認購約31.1倍,共有663名承配人,前25名承配人合共鎖定64.68%的發行股份

8、回撥情況:最大回撥,最終公開的比例爲11%,國配的比例爲89%

9、基石投資者(6名):高瓴、Tiger Global、清池資本、國調基金、GIC、貝萊德,合共鎖定38.83%的發行股份,禁售期6個月

10、超額配股權:國際發售已超額分配57,285,000股發售股份,有綠鞋

11、穩定價格操作人:美銀,穩價結束日爲2020年12月31日

12、關聯客戶(17名):合共鎖定3.22%的發行股份

13、uSMART盈立智投暗盤交易時間:12月7日16:15-18:30

注:以上股份佔比均爲假設超額配股權未獲行使

【中籤詳情】

甲組:

一手中籤率40%

申購200手穩中1手

申購600手穩中2手

申購1000手穩中3手

申購1400手(甲尾)穩中4手

乙組:

申購1600手(乙頭)穩中7手

申購2000手穩中8手

……

申購190950手穩中401手

以下爲中籤分配基準:

【基石投資者】

【股權集中度】

點擊可跳轉閱讀《京東健康發售價及配發結果公告》原文件PDF。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account